Venuto CS[au] - Search Results

Year	Number of Results
2007	1
2011	3
2012	1
2013	1
2014	2
2015	1
2016	3
2017	7
2018	1
2019	2
2020	4
2021	3
2022	2
2023	0

1

Pharmacologic approaches to the treatment of Huntington's disease.

Venuto CS, McGarry A, Ma Q, Kieburtz K. Venuto CS, et al. Mov Disord. 2012 Jan;27(1):31-41. doi: 10.1002/mds.23953. Epub 2011 Oct 13. Mov Disord. 2012. PMID: 21997232 Review.

2

Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's Disease.

Paracha M, Herbst K, Kieburtz K, Venuto CS. Paracha M, et al. Among authors: venuto cs. Mov Disord Clin Pract. 2022 Aug 18;9(7):961-966. doi: 10.1002/mdc3.13533. eCollection 2022 Oct. Mov Disord Clin Pract. 2022. PMID: 36247906 Free PMC article.

3

Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment.

Talal AH, Venuto CS, Younis I. Talal AH, et al. Among authors: venuto cs. Clin Pharmacol Drug Dev. 2017 Mar;6(2):206-212. doi: 10.1002/cpdd.336. Clin Pharmacol Drug Dev. 2017. PMID: 28263464 Free PMC article. Review.

4

A review of disease progression models of Parkinson's disease and applications in clinical trials.

Venuto CS, Potter NB, Dorsey ER, Kieburtz K. Venuto CS, et al. Mov Disord. 2016 Jul;31(7):947-956. doi: 10.1002/mds.26644. Epub 2016 May 26. Mov Disord. 2016. PMID: 27226141 Free PMC article. Review.

5

Isradipine plasma pharmacokinetics and exposure-response in early Parkinson's disease.

Venuto CS, Yang L, Javidnia M, Oakes D, James Surmeier D, Simuni T. Venuto CS, et al. Ann Clin Transl Neurol. 2021 Mar;8(3):603-612. doi: 10.1002/acn3.51300. Epub 2021 Jan 18. Ann Clin Transl Neurol. 2021. PMID: 33460320 Free PMC article. Clinical Trial.

6

Re-Analysis of the STEADY-PD II Trial-Evidence for Slowing the Progression of Parkinson's Disease.

Surmeier DJ, Nguyen JT, Lancki N, Venuto CS, Oakes D, Simuni T, Wyse RK. Surmeier DJ, et al. Among authors: venuto cs. Mov Disord. 2022 Feb;37(2):334-342. doi: 10.1002/mds.28850. Epub 2021 Nov 12. Mov Disord. 2022. PMID: 34766657 Free PMC article.

7

Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications.

Bednasz CJ, Venuto CS, Ma Q, Morse GD. Bednasz CJ, et al. Among authors: venuto cs. Clin Pharmacol Drug Dev. 2017 Mar;6(2):135-139. doi: 10.1002/cpdd.313. Clin Pharmacol Drug Dev. 2017. PMID: 28263465 Free PMC article. Review.

8

Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.

Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Yang Y, Wilding GE, Morse GD. Bednasz CJ, et al. Among authors: venuto cs. Ther Drug Monit. 2017 Dec;39(6):596-603. doi: 10.1097/FTD.0000000000000443. Ther Drug Monit. 2017. PMID: 29135907 Free PMC article.

9

Toward precision prescribing for methadone: Determinants of methadone deposition.

Talal AH, Ding Y, Venuto CS, Chakan LM, McLeod A, Dharia A, Morse GD, Brown LS, Markatou M, Kharasch ED. Talal AH, et al. Among authors: venuto cs. PLoS One. 2020 Apr 17;15(4):e0231467. doi: 10.1371/journal.pone.0231467. eCollection 2020. PLoS One. 2020. PMID: 32302325 Free PMC article.

10

Intrahepatic Sampling for the Elucidation of Antiviral Clinical Pharmacology.

Venuto CS, Talal AH. Venuto CS, et al. Clin Pharmacol Drug Dev. 2017 Mar;6(2):169-175. doi: 10.1002/cpdd.311. Clin Pharmacol Drug Dev. 2017. PMID: 28263459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results